Chemical, Pharmaceutical and Biotechnological Industry in Latvia

cover

OLAINFARM JSC

General Information
Registration number: 
40003007246
Year of foundation: 
1991
Industry (NACE 2): 
MANUFACTURING
20 Manufacture of chemicals and chemical products
20.1 Manufacture of basic chemicals, fertilisers and nitrogen compounds, plastics and synthetic rubber in primary forms
20.5 Manufacture of other chemical products
20.59 Manufacture of other chemical products n.e.c.
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 Manufacture of pharmaceutical preparations
21.20 Manufacture of pharmaceutical preparations
Head of the company, position: 
Mr Valērijs Maligins - Chairman of the Board
Number of employees: 
1 001 - 2 000
Turnover (EUR):
50 000 001 - ...
2016
50 000 001 - ...
2015
Export volume (EUR):
50 000 001 - ...
2016
50 000 001 - ...
2015
Export countries: 
Australia
Belarus
Bulgaria
Canada
Germany
Kazakhstan
Lithuania
Poland
Russia
Ukraine
United Kingdom
United States of America
Uzbekistan
Certificates: 
ISO 14001, ISO 17025 Laboratory Management System, EU GMP for APIs and FDFs, US cGMP for certain APIs (FDA), TGA for FDFs (Australia).
Contact Information
Address: 
Rūpnīcu street 5, Olaine, Olaines area, LV-2114, Latvia
Phone: 
+371-67013705
Fax: 
+371-67013777
E-mail: 
olainfarm [at] olainfarm [dot] lv
Contact person, position: 
Mr Valērijs Maligins - Chairman of the Board
Languages spoken : 
English
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

Production and sales of finished dosage forms (FDF), active pharmaceutical ingredients (API), intermediates and chemicals.

Olainfarm manufactures more than 60 FDFs in various forms. Key areas of specialisation include neurology (cholinesterase inhibitors, anxiolytics, psychostimulants, nootropics), cardiology (antiarrhythmics, energy metabolism enhancers), infectology (original nitrofurantoine derivatives and antivirals) and allergology (fast-acting antihistamines).

Olainfarm produces 28 different APIs and more than 20 intermediates and chemicals. The company is experienced in adamantane derivatives, quinuclidine derivatives, nitrofuran derivatives and optically pure g-aminobutyric acid derivatives, as well as in chiral compounds.

Cooperation interests: 

Outsourcing of analytical services, contract manufacturing, licensing of active substances.

Target export countries: 
Australia
Belarus
Bulgaria
Canada
Germany
Kazakhstan
Lithuania
Poland
Russia
Ukraine
United Kingdom
United States of America
Uzbekistan